Literature DB >> 3874021

Abnormal in vitro proliferation and differentiation of T colony forming cells in AIDS patients and clinically normal male homosexuals.

Y Lunardi-Iskandar, V Georgoulias, M Allouche, W Rozenbaum, D Klatzmann, M C Coll, P Meyer, J C Gluckman, M Gentilini, C Jasmin.   

Abstract

T cell colonies were generated from the peripheral blood and bone marrow of 11 patients with acquired immune deficiency syndrome (AIDS), 17 normal male and female heterosexuals and seven clinically normal male homosexuals. Mononuclear cells were cultured in methylcellulose both in the absence and presence of interleukin-2 (IL-2) containing conditioned medium. Clinically normal homosexuals showed a low number of T4+ (P less than 0.01) but not T8+ cells. The number of T cell colony forming cells (T-CFC) from both AIDS patients and homosexuals was significantly (P less than 0.01) reduced compared to T-CFC from normal heterosexuals. In seven and four out of 11 AIDS patients, T-CFC from peripheral blood and bone marrow, respectively, were able to generate colonies in the absence of added growth factors and/or mitogenic stimulation. Pooled spontaneous and induced colonies from AIDS patients as well as induced colonies from normal homosexuals were composed of immature cells bearing the T3+, T4+, T6+ T8+ surface phenotype, unlike colonies from normal heterosexuals which displayed mature cells bearing the T3+ T4+ T6- and T3+ T8+ T6- surface phenotype. Moreover, most T-CFC from primary spontaneous and induced colonies had lost their self-renewal capacity either in the absence or the presence of added growth factors. These results suggest that early impairment of T-CFC may play a predominant role in the pathogenesis of AIDS.

Entities:  

Mesh:

Year:  1985        PMID: 3874021      PMCID: PMC1577041     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Clonal proliferation of PHA-stimulated human lymphocytes in soft agar culture.

Authors:  L A Rozenszajn; D Shoham; I Kalechman
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

2.  Colony formation by human T lymphocytes in agar medium.

Authors:  M H Claësson; M B Rodger; G R Johnson; S Whittingham; D Metcalf
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  Deficient autologous mixed lymphocyte reaction in Kaposi's sarcoma associated with deficiency of Leu-3+ responder T cells.

Authors:  S Gupta; B Safai
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

4.  Characterization of the T lymphocyte colony-forming cells and evidence for the acquisition of T cell markers in the absence of the thymic microenvironment in man.

Authors:  F Triebel; W A Robinson; A R Hayward; P G de Laforest
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

5.  Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma.

Authors:  R E Stahl; A Friedman-Kien; R Dubin; M Marmor; S Zolla-Pazner
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

6.  Isolation of murine fetal hemopoietic progenitor cells and selective fractionation of various erythroid precursors.

Authors:  N A Nicola; D Metcalf; H von Melchner; A W Burgess
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

Review 7.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

8.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  A study of added GM-CSF independent granulocyte and macrophage precursors in mouse spleen infected with myeloproliferative sarcoma virus (MPSV).

Authors:  B Klein; C Le Bousse-Kerdiles; F Smadja-Joffe; I Pragnell; W Ostertag; C Jasmin
Journal:  Exp Hematol       Date:  1982-04       Impact factor: 3.084

10.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

View more
  5 in total

1.  Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.

Authors:  M Allouche; Y Lunardi-Iskandar; C Varela-Millot; M Itzhaki; P Cornuet; P Meyer; C Jasmin; V Georgoulias
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

2.  Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells.

Authors:  Y Lunardi-Iskandar; M T Nugeyre; V Georgoulias; F Barré-Sinoussi; C Jasmin; J C Chermann
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cells.

Authors:  A Ammar; C Cibert; A M Bertoli; V Tsilivakos; C Jasmin; V Georgoulias
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Defective T-cell differentiation in acquired immune deficiency syndrome (AIDS).

Authors:  E M Levy; J C Beldekas; K H Mayer; P H Black
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

5.  Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.

Authors:  Y Lunardi-Iskandar; A Gessain; V H Lam; R C Gallo
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.